Moreover, the inhibitory effect of pharmacological inhibition of glutamine metabolism by JHU083 on tumor growth was not as pronounced as that observed with genetic suppression of GTK as the tumors had already formed prior to JHU083 treatment. This evidence concerns the gene KYAT1 and neoplasm.